4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-019820
Chief Executive Officer sold 10,916 shares at an average $26.11 ($285,071)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham Chief Executive Officer | 2026-01-20 | Sale 10b5-1 | −5,833 | $26.12 | $152,333 | 562,080 | D |
| Ceesay Abraham Chief Executive Officer | 2026-01-20 | Sale 10b5-1 | −5,083 | $26.11 | $132,737 | 25,812 | I |
| Open-market sales · 10,916 sh · avg $26.11 · $285,071 | |||||||
Loading xslF345X05/ownership.xml…